NCT04966832View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of XW10508 Immediate and Modified Release Formulations in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

July 13, 2021

Primary Completion Date

June 13, 2022

Study Completion Date

June 13, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

XW10508

XW10508 capsules or tablets

OTHER

Placebo

Placebo capsules or tablets

Trial Locations (1)

5000

CMAX, Adelaide

Sponsors

Lead Sponsor

XWPharma
All Listed Sponsors
lead

XWPharma

INDUSTRY